The association of carcinoma of the uterine cervix with human papillom
avirus indicates that vaccine strategies which target the virus could
be useful in the control of disease progression. Recent advances have
centered on directing the immune response to prevention of infection,
to virus-infected (but nontransformed) cells and to virally transforme
d cells, with favourable results.